Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INCWST · Entity 3201 | Sr. VP & Chief HR Officer | September 11, 2026 | September 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
WEST PHARMACEUTICAL SERVICES INC
Report date September 11, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,817.8098 |
Ending reported balance
After 2026-09-15 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-09-11 · Exercise / conversion · Acquired 2,500 · Balance 24,317.8098 Row 2 · 2026-09-11 · Sale · Disposed 2,500 · Balance 21,817.8098 Row 3 · 2026-09-14 · Exercise / conversion · Acquired 2,500 · Balance 24,317.8098 Row 4 · 2026-09-14 · Sale · Disposed 2,500 · Balance 21,817.8098 Row 5 · 2026-09-15 · Exercise / conversion · Acquired 2,524 · Balance 24,341.8098 Row 6 · 2026-09-15 · Sale · Disposed 2,524 · Balance 21,817.8098 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $89.64 · Expires 2028-02-20 | Direct | 5,024 |
Reported balance
After 2026-09-11 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-11 · Exercise / conversion · Disposed 2,500 · Balance 5,024 F1: This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $89.64 · Expires 2028-02-20 | Direct | 2,524 |
Reported balance
After 2026-09-14 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-14 · Exercise / conversion · Disposed 2,500 · Balance 2,524 F1: This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $89.64 · Expires 2028-02-20 | Direct | 0 |
Reported balance
After 2026-09-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-09-15 · Exercise / conversion · Disposed 2,524 · Balance 0 F1: This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 15, 2026 20:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,524 | $0.00 Strike: $89.64 | $0.00 |
DisclosureSEC source: 0000105770-26-000110 · wk-form4_1789504664.xml · derivative · entry 9 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,524 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. Read SEC document |
| September 15, 2026 Filed Sep 15, 2026 20:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,524 | $365.00 | $921,260.00 |
DisclosureSEC source: 0000105770-26-000110 · wk-form4_1789504664.xml · nonDerivative · entry 6 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,817.8098 Read SEC document |
| September 15, 2026 Filed Sep 15, 2026 20:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 2,524 | $89.64 | $226,251.36 |
DisclosureSEC source: 0000105770-26-000110 · wk-form4_1789504664.xml · nonDerivative · entry 5 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,341.8098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 20:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $89.64 | $0.00 |
DisclosureSEC source: 0000105770-26-000110 · wk-form4_1789504664.xml · derivative · entry 8 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,524 Underlying: Common Stock · 2,500 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 20:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,500 | $355.00 | $887,500.00 |
DisclosureSEC source: 0000105770-26-000110 · wk-form4_1789504664.xml · nonDerivative · entry 4 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,817.8098 Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 20:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 2,500 | $89.64 | $224,100.00 |
DisclosureSEC source: 0000105770-26-000110 · wk-form4_1789504664.xml · nonDerivative · entry 3 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,317.8098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $89.64 | $0.00 |
DisclosureSEC source: 0000105770-26-000110 · wk-form4_1789504664.xml · derivative · entry 7 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,024 Underlying: Common Stock · 2,500 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,500 | $345.00 | $862,500.00 |
DisclosureSEC source: 0000105770-26-000110 · wk-form4_1789504664.xml · nonDerivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,817.8098 Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:37 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 2,500 | $89.64 | $224,100.00 |
DisclosureSEC source: 0000105770-26-000110 · wk-form4_1789504664.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,317.8098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $89.64 | $0.00 |
DisclosureSEC source: 0000105770-26-000108 · wk-form4_1789076210.xml · derivative · entry 9 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,524 Underlying: Common Stock · 2,500 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,818 | $0.00 Strike: $83.47 | $0.00 |
DisclosureSEC source: 0000105770-26-000108 · wk-form4_1789076210.xml · derivative · entry 8 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,818 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,817 | $0.00 Strike: $83.47 | $0.00 |
DisclosureSEC source: 0000105770-26-000108 · wk-form4_1789076210.xml · derivative · entry 7 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,818 Underlying: Common Stock · 2,817 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,500 | $340.81 | $852,025.00 |
DisclosureSEC source: 0000105770-26-000108 · wk-form4_1789076210.xml · nonDerivative · entry 6 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,844.5548 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 2,500 | $89.64 | $224,100.00 |
DisclosureSEC source: 0000105770-26-000108 · wk-form4_1789076210.xml · nonDerivative · entry 5 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,344.5548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,818 | $340.81 | $960,402.58 |
DisclosureSEC source: 0000105770-26-000108 · wk-form4_1789076210.xml · nonDerivative · entry 4 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,844.5548 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 2,818 | $83.47 | $235,218.46 |
DisclosureSEC source: 0000105770-26-000108 · wk-form4_1789076210.xml · nonDerivative · entry 3 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,662.5548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,817 | $340.81 | $960,061.77 |
DisclosureSEC source: 0000105770-26-000108 · wk-form4_1789076210.xml · nonDerivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,844.5548 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 2,817 | $83.47 | $235,134.99 |
DisclosureSEC source: 0000105770-26-000108 · wk-form4_1789076210.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,661.5548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 16:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,817 | $0.00 Strike: $83.47 | $0.00 |
DisclosureSEC source: 0000105770-26-000054 · form4.xml · derivative · entry 4 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,635 Underlying: Common Stock · 2,817 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 16:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,817 | $305.20 | $859,753.47 |
DisclosureSEC source: 0000105770-26-000054 · form4.xml · nonDerivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,828.4906 F1 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 16:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 2,817 | $83.47 | $235,134.99 |
DisclosureSEC source: 0000105770-26-000054 · form4.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,645.4906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:30 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Option (Right to Buy) · Derivative | 1,712 | $0.00 Strike: $254.34 | $0.00 |
DisclosureSEC source: 0000105770-26-000037 · form4.xml · derivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,712 Underlying: Common Stock · 1,712 shares Expires 2036-03-01 F3 · derivative.exercise_date: The stock option vests in four equal annual installments beginning on March 1, 2027. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:30 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantRst. Stock Unit · Derivative | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0000105770-26-000037 · form4.xml · derivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of WST common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on March 1, 2027. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on March 1, 2027. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 23:58 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionRst. Stock Unit · Derivative | 135.491 | $0.00 | $0.00 |
DisclosureSEC source: 0000105770-26-000016 · form4.xml · derivative · entry 6 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 408.486 Underlying: Common Stock · 135.491 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On February 18, 2025, the reporting person was granted 542 restricted stock units, vesting in four equal annual installments (plus dividend equivalents). F3 · derivative.expiration_date: On February 18, 2025, the reporting person was granted 542 restricted stock units, vesting in four equal annual installments (plus dividend equivalents). Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 23:58 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Tax withholdingCommon Stock | 35.757 | $248.26 | $8,877.03 |
DisclosureSEC source: 0000105770-26-000016 · form4.xml · nonDerivative · entry 4 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,374.4904 Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 23:58 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 135.491 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000105770-26-000016 · form4.xml · nonDerivative · entry 3 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,410.2474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 23:58 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Tax withholdingCommon Stock | 150.443 | $243.19 | $36,586.23 |
DisclosureSEC source: 0000105770-26-000016 · form4.xml · nonDerivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,274.7564 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 23:58 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 441.957 | $0.00 | $0.00 |
DisclosureSEC source: 0000105770-26-000016 · form4.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,425.1994 F1 · shares: These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 02:11 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantRst. Stock Unit · Derivative | 542 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006119 · form4.xml · derivative · entry 4 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 542 Underlying: Common Stock · 542 shares Expires not disclosed F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026. F1 · derivative.expiration_date: This award vests in four equal installments beginning on February 18, 2026. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 02:11 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Option (Right to Buy) · Derivative | 1,251 | $0.00 Strike: $211.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006119 · form4.xml · derivative · entry 3 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,251 Underlying: Common Stock · 1,251 shares Expires 2035-02-18 F1 · derivative.exercise_date: This award vests in four equal installments beginning on February 18, 2026. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 02:11 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Tax withholdingCommon Stock | 83.794 | $211.00 | $17,680.53 |
DisclosureSEC source: 0001127602-25-006119 · form4.xml · nonDerivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,738.7407 Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 02:11 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 246.162 | $211.00 | $51,940.18 |
DisclosureSEC source: 0001127602-25-006119 · form4.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,822.5347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 23:20 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to Buy) · Derivative | 2,597 | $0.00 Strike: $350.18 | $0.00 |
DisclosureSEC source: 0001127602-24-006391 · form4.xml · derivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,597 Underlying: Stock Options (Right to Buy) · 2,597 shares Expires 2034-02-20 F2 · derivative.exercise_date: This grant vests in four equal installments beginning on February 20, 2025. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 23:20 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 541 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-006391 · form4.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,503.2217 F1 · security: 2021 PSUs (PP20) award vesting net of taxes withheld. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 21:36 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GiftCommon Stock | 584 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029589 · form4.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,962.2217 F1 · kind: Charitable contribution of shares to a donor advised fund Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 19:46 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to buy) · Derivative | 2,000 | $0.00 Strike: $83.47 | $0.00 |
DisclosureSEC source: 0001562180-23-006659 · primarydocument.xml · derivative · entry 4 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,452 Underlying: Common Stock · 2,000 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 19:46 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 1,240 | $414.91 | $514,488.65 |
DisclosureSEC source: 0001562180-23-006659 · primarydocument.xml · nonDerivative · entry 3 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,876.9617 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $414.58 to $415.08, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 19:46 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 760 | $414.20 | $314,788.20 |
DisclosureSEC source: 0001562180-23-006659 · primarydocument.xml · nonDerivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,116.9617 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $413.58 to $414.57, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 19:46 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 2,000 | $83.47 | $166,940.00 |
DisclosureSEC source: 0001562180-23-006659 · primarydocument.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,876.9617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2023 Filed May 2, 2023 17:53 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,012 | $0.00 Strike: $59.64 | $0.00 |
DisclosureSEC source: 0001562180-23-003794 · primarydocument.xml · derivative · entry 5 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,012 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2023 Filed May 2, 2023 17:53 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 900 | $367.45 | $330,707.43 |
DisclosureSEC source: 0001562180-23-003794 · primarydocument.xml · nonDerivative · entry 4 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,876.9617 F3 · price: This transaction was executed in multiple trades at prices ranging from $367.03 USD to $367.98 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| May 01, 2023 Filed May 2, 2023 17:53 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,687 | $366.46 | $984,686.62 |
DisclosureSEC source: 0001562180-23-003794 · primarydocument.xml · nonDerivative · entry 3 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,776.9617 F2 · price: This transaction was executed in multiple trades at prices ranging from $366.01 USD to $366.985 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| May 01, 2023 Filed May 2, 2023 17:53 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 9,425 | $365.47 | $3,444,538.73 |
DisclosureSEC source: 0001562180-23-003794 · primarydocument.xml · nonDerivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,463.9617 F1 · price: This transaction was executed in multiple trades at prices ranging from $365.00 USD to $365.97 USD; the price reported above reflects the weighted average sale price. Read SEC document |
| May 01, 2023 Filed May 2, 2023 17:53 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 13,012 | $59.64 | $776,035.68 |
DisclosureSEC source: 0001562180-23-003794 · primarydocument.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,888.9617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 23:24 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to buy) · Derivative | 2,988 | $0.00 Strike: $306.68 | $0.00 |
DisclosureSEC source: 0001562180-23-001793 · primarydocument.xml · derivative · entry 2 Favorite Annette F · CIK 0001654975 · Sr. VP Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,988 Underlying: Stock Options (Right to Buy) · 2,988 shares Expires 2033-02-21 F2 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 21, 2024. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 23:24 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 1,740 | $306.68 | $533,623.20 |
DisclosureSEC source: 0001562180-23-001793 · primarydocument.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,876.9617 F1 · shares: 2020 PSUs (PP19) award vesting net of taxes withheld Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:55 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to buy) · Derivative | 3,108 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001883 · primarydocument.xml · derivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,108 Underlying: Stock Options (Right to Buy) · 3,108 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 20:28 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 2,490 | $369.13 | $919,133.70 |
DisclosureSEC source: 0001562180-22-001858 · primarydocument.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,136.9617 F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:44 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to buy) · Derivative | 3,968 | $0.00 Strike: $274.29 | $0.00 |
DisclosureSEC source: 0001562180-21-001591 · primarydocument.xml · derivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,968 Underlying: Common Stock · 3,968 shares Expires 2031-02-23 F1 · derivative.exercise_date: This award vests in 4 equal annual installments beginning on 2/23/2022. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:33 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 2,438 | $272.65 | $664,720.70 |
DisclosureSEC source: 0001562180-21-001573 · primarydocument.xml · nonDerivative · entry 1 Favorite Annette F · CIK 0001654975 · Sr. VP Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,646.9617 F1 · shares: 2018 PSUs (PP17) award vesting net of taxes withheld Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.